Isabelle Andrieux‐Meyer

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

Christian Laurent, Charles Kouanfack, Sinata Koulla‐Shiro et al. · The Lancet · 2004 · 305 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +13

Field Assessment of Generic Antiretroviral Drugs: A Prospective Cohort Study in Cameroon

Anke Bourgeois, Christian Laurent, Rose Mougnutou et al. · Antiviral Therapy · 2005 · 46 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial

Isabelle Andrieux‐Meyer, Soek-Siam Tan, Sombat Thanprasertsuk et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries

Andrew Hill, Dzintars Gotham, Graham Cooke et al. · Journal of Virus Eradication · 2015 · 35 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries

Nathan Ford, Stefan Z. Wiktor, Karyn Kaplan et al. · International Journal of Drug Policy · 2015 · 32 citations

Public Affairs, Health Policy, Public Health Practice +14